Imagene
Founded 2020 · 38 employees on LinkedIn · 1 known investors
Find your way into Imagene
Sign up to see every warm intro you have to Imagene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imagene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Imagene develops AI-based oncology intelligence that turns cancer data into insights to support patient care and drug development. It serves the biotech and clinical oncology market, working with scientists, physicians, and therapy developers.
Founders & leadership
Imagene was founded in 2020 by Dean Bitan, Jonathan Zalach, and Shahar Porat.



Investors · 1
How we know: Blumberg Capital's portfolio page · the company's own site · funding news · hitconsultant.net · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingMay 2022
Blumberg Capital (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Imagene do?
- Imagene develops AI-based oncology intelligence that turns cancer data into insights to support patient care and drug development. It serves the biotech and clinical oncology market, working with scientists, physicians, and therapy developers.
- Who founded Imagene?
- Imagene was founded by Dean Bitan, Jonathan Zalach, Shahar Porat in 2020.
- Who are Imagene's investors?
- Imagene's investors include Blumberg Capital.

